Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Labeller names
- 2
- Live patents
- 3
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 human prescription drug. By marketing category: BLA 3, NDA 3.
| Dosage form | NDCs |
|---|---|
| capsule | 3 |
| injection | 3 |
| Route | NDCs |
|---|---|
| intravenous | 3 |
| oral | 3 |
| Labeller name on the listing | NDCs |
|---|---|
| biogen ma inc | 3 |
| biogen ma inc. | 3 |
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10385341 | QALSODYtofersen | substance, product | Apr 2035 |
| 10669546 | QALSODYtofersen | use | Apr 2035 |
| 10968453 | QALSODYtofersen | use | Apr 2035 |
| Product | Exclusivity | Until |
|---|---|---|
| QALSODYTOFERSEN | ODE-432 Orphan drug | Apr 2030 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Tofidence | Tocilizumab | injection, intravenous | 64406-022BLA |
| Tofidence | Tocilizumab | injection, intravenous | 64406-023BLA |
| Tofidence | Tocilizumab | injection, intravenous | 64406-024BLA |
| ZURZUVAE | zuranolone | capsule, oral | 64406-029NDA |
| ZURZUVAE | zuranolone | capsule, oral | 64406-030NDA |
| ZURZUVAE | zuranolone | capsule, oral | 64406-031NDA |
Compare
Other companies listing tocilizumab
- Lonza Biologics Inc15 sites · 80 NDC
- Genentech, Inc.8 sites · 93 NDC
- Chugai Pharmaceutical Co., Ltd.3 sites · 13 NDC
- Genentech, Inc. (SSF)0 sites · 2 NDC
Enquiry
Common questions
- Is Biogen MA Inc. FDA approved?
- Biogen MA Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Biogen MA Inc. make?
- 6 products are listed under Biogen MA Inc. in the openFDA NDC Directory, most often as capsule; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.